Back to Search
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age
River Forest, Illinois, 60305
Columbus, Georgia, 31904
New Orleans, Louisiana, 70115
Lakeland, Florida, 33805
Miami, Florida, 33186
Columbus, Georgia, 31904
New Orleans, Louisiana, 70115
Lakeland, Florida, 33805
Miami, Florida, 33186
Search open until 11/28/2024
The main purpose of this first-in-human study is to generate sufficient safety and immunogenicity data to enable the selection of an appropriate dose level for the initiation of a Phase 2/3 study.
Eligibility
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, learn about Clinical
| Ages Eligible for Study | Min Age: 50 years - Max Age: N/A |
| Sexes Eligible for Study | All |
| Accepts Healthy Volunteers | Yes |
Visit ClinicalTrials.Gov for more information
Support nonprofit organizations through participating in clinical trials at no cost to you
You may also be interested in
Tuscaloosa, Alabama and more
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
Neurobehavioral Disinhibition Read more
Rockville, Maryland and more
A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults
Seasonal Influenza Read more
Oklahoma City, Oklahoma and more